U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

…, R Emma, M Ericsson, V Erpenbeck, D Erzen… - Journal of Allergy and …, 2017 - Elsevier
Background Asthma is a heterogeneous disease in which there is a differential response to
asthma treatments. This heterogeneity needs to be evaluated so that a personalized …

Effect of bronchodilation, exercise training, and behavior modification on symptoms and physical activity in chronic obstructive pulmonary disease

…, W Janssens, J Garcia-Aymerich, D Erzen… - American Journal of …, 2018 - atsjournals.org
Rationale: Bronchodilation and exercise training (ExT) improve exercise tolerance in patients
with chronic obstructive pulmonary disease (COPD); however, behavior modification is …

Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised …

T Troosters, J Bourbeau, F Maltais, N Leidy, D Erzen… - BMJ open, 2016 - bmjopen.bmj.com
Introduction Chronic obstructive pulmonary disease (COPD) is associated with exercise
limitation and physical inactivity, which are believed to have significant long-term negative …

Validity and responsiveness of the Daily-and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments

…, C De Jong, H Demeyer, F Dobbels, D Erzen… - Thorax, 2021 - thorax.bmj.com
Background The Daily-PROactive and Clinical visit-PROactive Physical Activity (D-PPAC
and C-PPAC) instruments in chronic obstructive pulmonary disease (COPD) combines …

Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation

…, KL Lavoie, M Sedeno, D De Sousa, D Erzen… - BMJ open, 2016 - bmjopen.bmj.com
Introduction Chronic obstructive pulmonary disease is generally progressive and associated
with reduced physical activity. Both pharmacological therapy and exercise training can …

Phase I study of the VEGF/Ang-2 inhibitor BI 836880 alone or combined with the anti-programmed cell death protein-1 antibody ezabenlimab in Japanese patients …

…, T Shimizu, A Todaka, T Kawakami, D Erzen… - Cancer Chemotherapy …, 2023 - Springer
Purpose This two-part, open-label, non-randomized dose-escalation study aimed to define
the maximum tolerated dose (MTD) of BI 836880 (humanized bispecific nanobody® targeting …

Molecular epidemiology of tuberculosis in Slovenia: results of a one-year (2001) nation-wide study

M Žolnir-dovč, M Poljak, D Eržen… - Scandinavian journal of …, 2003 - Taylor & Francis
Slovenia is a small Central European country with a population of 1.99 million and an incidence
of tuberculosis (TB) of 18.6 per 100,000 inhabitants in 2001. In a prospective nation-wide…

Aerosolized clindamycin is superior to aerosolized dexamethasone or clindamycin-dexamethasone combination in the treatment of severe Porphyromonas gingivalis …

…, Z Pavlica, A Nemec-Svete, D Eržen… - Experimental Lung …, 2012 - Taylor & Francis
Adjunctive corticosteroid treatment to reduce excessive local inflammatory response in
pneumonia is controversial. To study the effects of an early local adjunct dexamethasone …

Mechanisms associated with increased physical activity in patients undergoing self-management behaviour modification in the randomised PHYSACTO trial

…, D De Sousa, F Maltais, D Erzen… - ERJ Open …, 2021 - Eur Respiratory Soc
Introduction In this analysis of the PHYSACTO® study, we assessed the efficacy of a self-management
behaviour modification (SMBM) programme to improve physical activity (PA) …

Changes in asthma severity in Manitoba

D Erzen, LL Roos, J Manfreda, NR Anthonisen - Chest, 1995 - Elsevier
Objective: To assess changes in the severity of physician-diagnosed asthma between 1983
and 1988. Design: Cross-sectional studies examining the frequency of markers of asthma …